GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.8004
-0.0596 (-6.93%)
At close: May 8, 2026, 4:00 PM EDT
0.7900
-0.0104 (-1.30%)
After-hours: May 8, 2026, 7:59 PM EDT
GlucoTrack Employees
GlucoTrack had 15 employees as of December 31, 2025. The number of employees increased by 4 or 36.36% compared to the previous year.
Employees
15
Change (1Y)
4
Growth (1Y)
36.36%
Revenue / Employee
n/a
Profits / Employee
-$1,762,545
Market Cap
2.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 15 | 4 | 36.36% | 15 | 0 |
| Dec 31, 2024 | 11 | 5 | 83.33% | 11 | 0 |
| Dec 31, 2023 | 6 | 3 | 100.00% | 6 | 0 |
| Dec 31, 2022 | 3 | -2 | -40.00% | 3 | 0 |
| Dec 31, 2021 | 5 | -6 | -54.55% | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Bionano Genomics | 97 |
| Femasys | 54 |
| Nephros | 36 |
| NEXGEL | 19 |
| Milestone Scientific | 15 |
GCTK News
- 2 days ago - GlucoTrack submits IDE application to initiate study for CBGM technology - TheFly
- 2 days ago - Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology - GlobeNewsWire
- 9 days ago - Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology - GlobeNewsWire
- 18 days ago - GlucoTrack announces publication of peer-reviewed article on glucose sensors - TheFly
- 18 days ago - Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology - GlobeNewsWire
- 5 weeks ago - Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Why is Glucotrack Stock (GCTK) Up Nearly 30% Today? - TipRanks
- 6 weeks ago - GlucoTrack to file IDE to FDA for continuous blood glucose monitoring technology - TheFly